Left ventricular ejection fraction to predict early mortality in patients with non-ST-segment elevation acute coronary syndromes

American Heart Journal

Volumn 150, Issue 2, 2005, Pages 215-220

  Bosch, Xavier ^a   Théroux, Pierre ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; ELECTROCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE REGRESSION; PRIORITY JOURNAL; PROGNOSIS; ROC CURVE; ST SEGMENT; ST SEGMENT ELEVATION; STATISTICAL MODEL;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CANADA; CREATINE KINASE, MB FORM; ELECTROCARDIOGRAPHY; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; REGISTRIES; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; SPAIN; STROKE VOLUME;

EID: 23644462454     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.09.027     Document Type: Article

References (28)

1. E. Braunwald, E.M. Antman, and J.W. Beasley ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) Circulation 106 2002 1893 1900
2. M.E. Bertrand, M.L. Simoons, and K.A. Fox Management of acute coronary syndromes in patients presenting without ST-segment elevation. The Task Force of the European Society of Cardiology Eur Heart J 23 2002 1809 1840
3. E. Boersma, K.S. Pieper, and E.W. Steyerberg Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients Circulation 101 2000 2557 2567
4. E.M. Antman, M. Cohen, and P.J.L. Bernink The TIMI risk score for unstable angina/non-ST elevation MI. A method for prognostication and therapeutic decision-making JAMA 284 2000 835 842
5. M.S. Sabatine, J.L. Januzzi, and S. Snapinn A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris Am J Cardiol 88 2001 488 492
6. C.P. Cannon, W.S. Weintraub, and L.A. Demopoulos Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
7. D.A. Morrow, E.M. Antman, and S.M. Snapinn An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes: application of the TIMI risk score for UA/NSTEMI in PRISM-PLUS Eur Heart J 23 2002 223 229
8. A. Budaj, S. Yusuf, and S.R. Mehta Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups Circulation 106 2002 1622 1626
9. M. Emond, M.B. Mock, and K.B. Davis Long-term survival of medically treated patients in the Coronary Artery Surgery Study (CASS) registry Circulation 90 1994 2645 2657
10. D. Brezinski, P.H. Stone, and J.E. Muller Prognostic significance of the Karnofsky performance status score in patients with acute myocardial infarction: comparison with the left ventricular ejection fraction and the exercise treadmill test performance. The MILIS study group Am Heart J 121 1991 1374 1381
11. A. Volpi, C. De Vita, and M.G. Franzosi Determinants of 6-month mortality in survivors of myocardial infarction after thrombolysis: results of the GISSI-2 data base. The ad hoc working group of the Gruppo Iyaliano per lo Studio della Sopravivenza nell'Infarto Miocardico (GISSI)-2 data base Circulation 88 1993 416 429
12. The PRISM-PLUS Study Investigators Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction N Engl J Med 338 1998 1488 1497
13. E. Braunwald Unstable angina. A classification Circulation 80 1989 410 414
14. F. Harrell, and K.L. Lee Regression modeling strategies for improved prognostic prediction Stat Med 3 1984 143 152
15. M. Cohen, C. Demers, and E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events study group N Engl J Med 337 1997 447 452
16. E.M. Antman, C.H. McCabe, and E.P. Gurfinkel Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial Circulation 100 1999 1593 1601
17. The PURSUIT Trial Investigators Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes N Engl J Med 339 1998 436 443
18. M.L. Simoons Effect of glycoprotein IIb/IIIa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation: the GUSTO IV-ACS randomised trial Lancet 357 2001 1899 1900
19. FRagmin, and Fast Revascularization during Instability in Coronary Artery Disease Investigators Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomised multicentre study Lancet 354 1999 708 715
20. J.W. Hoekstra, C.V. Pollack, and M.T. Roe Improving the care of patients with non-ST-elevation acute coronary syndromes in the emergency department: the CRUSADE initiative Acad Emerg Med 9 2002 1146 1155
21. K.A.A. Fox, S.G. Goodman, and W. Klein Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 23 2002 1177 1189
22. D. Hasdai, S. Behar, and L. Wallentin A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J 23 2002 1190 1201
23. X. Bosch, E. López de Sá, and J. López Sendón Clinical characteristics, prognosis, and variability in the management of non-ST-segment elevation acute coronary syndromes. Data from the PEPA registry Rev Esp Cardiol 56 2003 346 353
24. R.J. Luchi, S.M. Scott, and R.H. Deupree Principal investigators and their associates of Veterans Administration Cooperative Study No. 28: comparison of medical and surgical treatment for unstable angina pectoris N Engl J Med 316 1987 977 984
25. J.A. Goldstein, D. Demetriou, and C.L. Grines Multiple complex coronary plaques in patients with acute myocardial infarction N Engl J Med 343 2000 915 922
26. G. Rioufol, G. Finet, and X. André-Fouet Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study Circulation 106 2002 804 808
27. J.A. De Lemos, D.A. Morrow, and J.H. Bentley The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes N Engl J Med 345 2001 1014 1021
28. S.K. James, B. Lindahl, and A. Siegbahn N-Terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a global utilization of strategies to open occluded arteries (GUSTO)-IV substudy Circulation 108 2003 275 281